213
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Acute and sub-acute oral toxicity assessment of 5-hydroxy-1,4-naphthoquinone in mice

, , , , , , , & show all
Pages 795-808 | Received 21 Feb 2022, Accepted 17 Jul 2022, Published online: 28 Jul 2022
 

Abstract

5-hydroxy-1,4-naphthoquinone (5NQ) or juglone is a bioactive molecule found in walnuts and has shown therapeutic effects in various disease models. Limited information is available regarding the toxicity of 5NQ, thereby limiting the clinical development of this drug. In the present study, oral acute (50, 300 and 2000mg/kg) and sub-acute toxicity (5, 15 and 50mg/kg) was assessed in mice to evaluate the safety of 5NQ. The acute toxicity study identified 118mg/kg as the point-of-departure dose (POD) for single oral administration of 5NQ using benchmark dose modeling (BMD). Repeated administration of 5NQ at doses of 15 and 50mg/kg/day caused reduction in food consumption and body weight of mice along with alterations in liver and renal function. Histopathological assessment revealed significant damage to hepatic and renal tissues at all doses in the acute toxicity study, and at higher doses of 15 and 50mg/kg in the sub-acute toxicity study. We observed dose dependent mortality in sub-acute toxicity study and the no observed adverse effect level (NOAEL) was established as < 5mg/kg/day. Modeling the survival response in sub-acute toxicity study identified 1.74mg/kg/day as the POD for repeated administration of 5NQ. Serum levels of aspartate aminotransferase (AST) were most sensitive to 5NQ administration with a lower limit of BMD interval (BMDL) of 1.1 × 10−3mg/kg/day. The benchmark doses reported in the study can be further used to determine a reference dose of 5NQ for human risk assessment.

Acknowledgement

The authors would like to thank Dr. Sharath Kumar H J, Clinical Pharmacology Lab, ACTREC, and Mr. Soutik Halder, TMC Central Biostatistical Cell, Clinical Research Secretariat & DAE-CTC, TMH, for assistance in Benchmark dose analysis.

Disclosure statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,271.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.